Synthesis of the E ring of gambierol

DOI: 10.1016/S0040-4039(98)01311-2

Source and publish data:

Tetrahedron Letters p. 6369 - 6372 (1998)

Update date:2022-08-03

Topics:

Authors:

Kadota, Isao

Kadowaki, Chie

Yoshida, Noriko

Yamamoto, Yoshinori

Read Full Text PDF DownLoad Join now for total 90,000,000 free articles

Article abstract of DOI:10.1016/S0040-4039(98)01311-2

The synthesis of the E ring of gambierol was achieved from D-ribose via the intramolecular reaction of allylstannane with an aldehyde as a key step. The undesired stereoisomer formed in this reaction was converted to the desired product by using DBU isome

Full text of DOI:10.1016/S0040-4039(98)01311-2

Products guided by the article

Product name:(2S,4R,5S)-4-[3-(tert-Butyl-diphenyl-silanyloxy)-propyl]-2-phenyl-[1,3]dioxan-5-ol

Cas No:213766-24-6

R&D Labs maybe for 213766-24-6

C-LAB Chemievermittlung GmbH

Contact:+49-9398-993127

Address:Untertorstr. 27
Tianjin Boron PharmaTech Co.,Ltd.(expird)

Contact:86-022-59845187

Address:B9-401, Tianda Science Park,No.80,4th Avenue,TEDA,Tianjin, China
Shanghai PuYi Chem-Tech Co.,Ltd.

Contact:+86-21-57687505-227

Address:3 Floor, Building 11, No 201 MinYi Road, Songjiang District, Shanghai 201612, China
Zhejiang Allied Chemical Co.,Ltd

Contact:18967038207

Address:Area A-30, High-tech Industrial Park, Quzhou, Zhejiang, China.
NEW FORTUNE INDUSTRIAL CO.,LTD.

website:http://newfortune.lookchem.com/

Contact:+86-25-8645-9456

Address:C4-105 GREEN ISLAND FLOWER TOWN

Relevant to this article

Doi:10.1016/S0008-6215(00)83477-1
(1978)
An Intramolecular Allenic [2 + 2 + 1] Cycloaddition

Doi:10.1021/jo980548c
(1998)
Synthesis, Characterization, and Bromine Substitution of Diamine Complexes of Carboxyborane and Methoxycarbonylborane. Diazabora Rings Containing B-Carboxyl and B-Carboxylato Groups

Doi:10.1021/ic9713442
(1998)
Copper-promoted oxidative-fluorination of arylphosphine under mild conditions

Doi:10.1039/c4cc04830j
(2014)
Doi:10.1039/CT8966901265
()
Discovery of a highly potent, functionally-selective muscarinic M₁ agonist, WAY-132983 using rational drug design and receptor modelling

Doi:10.1016/S0960-894X(99)00313-3
(1999)

Article Doi